Pär Halje will coordinate the new AI initiative. From January 2022, MultiPark will have its own coordinator for projects involving Artificial Intelligence. Pär Halje is an assistant researcher in Per Petersson’s Integrative Neurophysiology and Neurotechnology group. For a one year trial period, he will spend 20 % of his time facilitating the implementation of artificial intelligence (AI) tools in

https://www.multipark.lu.se/article/multipark-investing-artificial-intelligence - 2025-08-23

A mental hug to all MultiPark members from the wintry Scanian coast. The best of MultiPark 2021 and looking forward to 2022. As 2021 turns towards its end, we can look back on the many positive events we managed to land together this year. In particular, We have awarded salary support for Ph.D. students and young group leaders, which has broadly benefitted our community. We have formed a networkin

https://www.multipark.lu.se/article/season-greetings-coordinator - 2025-08-23

A human midbrain organoid visualised by staining for proteins important during the maturation of dopaminergic neurons. (photo: Alessandro Fiorenzano) In their latest study, published in Nature Communications, the Parmar Lab has established midbrain organoids using silk microfibers as scaffolds, offering a refined in vitro model of human midbrain development. They have studied their silk midbrain o

https://www.multipark.lu.se/article/human-midbrain-organoids-grown-silk-recapitulate-midbrain-development-and-support-functionally - 2025-08-23

Elin Byman defends her thesis on the 21st of January 2022. During her thesis project, Elin Byman discovered a role of alpha-amylase in Alzheimer’s disease. January 21, she defends her Ph.D. work supervised by Malin Wennström in the Preclinical memory research group at MultiPark. Here, she tells about the journey and major breakthroughs. Tell us about your research! The enzyme alpha-amylase has lon

https://www.multipark.lu.se/article/phd-defence-interview-elin-byman - 2025-08-23

Sabine Konings defends her thesis on the 27th of January 2022. Sabine Konings’ Ph.D. project sheds light on the role of different genetic variants of apolipoprotein E in early Alzheimer’s disease development. January 27, she defends her thesis. In this interview, she shares the most important findings as a Ph.D. student in the Experimental Dementia group. Tell us about your research! Apolipoprotei

https://www.multipark.lu.se/article/phd-defence-interview-sabine-konings - 2025-08-23

The translational project aims at developing aligned methodologies to unravel abnormal movement features in rodent models of Parkinson’s disease and human patients. Illustration: Laura Andreoli MultiPark leads one of the four projects recently selected by Lund University to pursue emerging research topics. The project eSCIENCE MOVES will apply artificial intelligence and machine learning to achiev

https://www.multipark.lu.se/article/escience-translational-movement-analysis - 2025-08-23

The PI retreat in January resulted in a groundbreaking decision: MultiPark’s working groups should be replaced by a more dynamic organization including both "special interest groups” and “task force groups”. Here is what will happen. Discussing the MultiPark seven translational working groups was an important point in the agenda of the PI member retreat in January. Already while planning for the m

https://www.multipark.lu.se/article/working-groups-renovation-progress - 2025-08-23

Caroline Haikal defends her thesis on the 11th of March 2022. During her Ph.D. studies, Caroline Haikal has investigated the connections between the gut and the brain in early Parkinson’s disease development. On March 11, she defends her work supervised by Prof. Jia-Yi Li. Here, Caroline tells us about her research in Neural Plasticity and Repair, one of MultiPark’s experimental research groups. T

https://www.multipark.lu.se/article/phd-defence-interview-caroline-haikal - 2025-08-23

Photo:Mostphotos Better treatment with the Mange PD tool. A biobank that opens up for discoveries about disease development. Keys to life satisfaction in people with Parkinson’s disease. New insights into toxic protein aggregation. And a more detailed knowledge of abnormal movement patterns with artificial intelligence. Just to mention a few of all news related to Parkinson’s disease from the stra

https://www.multipark.lu.se/article/world-parkinsons-day-five-promising-research-projects-multipark - 2025-08-23

Maurits Johansson defends his thesis on the 13th of May 2022. Maurits Johansson investigates neuropsychiatric symptoms in the early stages of Alzheimer’s disease, before cognitive impairments are developed or diagnosis is set. He defends his thesis on May 13. Here, he shares the most important findings and experiences as a Ph.D. student at the Clinical Memory Research Unit. Tell us about your rese

https://www.multipark.lu.se/article/phd-defence-interview-maurits-johansson - 2025-08-23

Image: Ben Sweet Two young experimental researchers have been awarded grants from the Anna-Lisa Rosenberg Foundation, the Department of Experimental Medical Science´s own grant for research in the neurobiological field with a clinical collaboration. Congratulations Alessandro Fiorenzano on the Anna-Lisa Rosengren Foundation grant, 65 000 SEK, how does it feel? – I am grateful for this fantastic op

https://www.multipark.lu.se/article/young-neurobiologists-awarded-grants-alzheimers-and-parkinsons-research - 2025-08-23

Oscar Manouchehrian defends his thesis on the 13th of May 2022. Oscar Manouchehrian has explored the roles of exercise and inflammation in neurological disorders. On May 13, he defends his Ph.D. thesis. Here, he shares his insights into academic research and experiences as a Ph.D. student in the Experimental Neuroinflammation Laboratory at MultiPark. Tell us about your research! My research engage

https://www.multipark.lu.se/article/phd-interview-oscar-manouchehrian - 2025-08-23

One of the Electrophysiology Core Facilities' rigs in use during an experiment. Photo credit: Johan Persson. This year Lund Stem Cell Center and MultiPark, two strategic research areas based at Lund University, are happy to launch a new joint technical platform in an effort to ensure easy access to high quality core electrophysiology techniques and expert knowledge for investigating cells and tiss

https://www.multipark.lu.se/article/high-quality-electrophysiology-facilities-multipark-and-lund-scc-join-forces - 2025-08-23

Fluorescent microscope image of control MBP-positive oligodendrocytes (in green) co-stained with alpha-synuclein (in red). It is possible to observe neurites positive for alpha-synuclein. Photo Credit: Carla Azevedo. Researchers from Lund University, led by Dr. Laurent Roybon, are working to further define underlying mechanisms involved in neurodegenerative diseases, such as Parkinson’s Disease an

https://www.multipark.lu.se/article/new-findings-may-lead-way-future-therapeutic-approaches-parkinsons-disease-and-similar-diseases - 2025-08-23

iStock/Jolygon Frontotemporal dementia begins relatively early compared to other forms of dementia. We still know relatively little about what causes the disease, however, new research from Lund University in Sweden shows that the folds in the brain that are formed in the latter stages of pregnancy could have an impact on the age at which the disease takes hold. Those affected by frontotemporal de

https://www.multipark.lu.se/article/brain-folds-formed-during-foetal-stage-could-affect-onset-dementia - 2025-08-23

Photo: Mostphotos In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur because of tissue changes in the brain, or whether they represent psychological reactions to cognitive symptoms. A study from Lund University in Sweden has provided new insight, and is published in Bi

https://www.multipark.lu.se/article/psychiatric-symptoms-alzheimers-disease - 2025-08-23

A laboratory expert in action in the Cell and Gene Therapy Core Facility. Earlier this year, Stem Cell Center, in partnership with MultiPark, brought together three core facilities into one - The Cell and Gene Therapy Core Facility - aiming to support advanced science at the highest international level. This new infrastructure includes the previous AAV vector lab, and much more! Equipped with the

https://www.multipark.lu.se/article/new-cell-and-gene-therapy-core-facility-opening - 2025-08-23

Photo: Mostphotos The MultiPark backbone for research interactions is about to be reorganized. Thanks to our members' suggestions, we are now creating 13 special interest groups to address important scientific and technological areas. The process of finding engaged leaders for these groups is about to start, providing opportunities for professional development and network formation to our young sc

https://www.multipark.lu.se/article/special-interest-groups-open-more-collaboration-within-multipark - 2025-08-23

Åsa Petersén has been researching Huntington’s disease for 25 years and means that a lot can be done to reduce suffering, increase quality of life and make various adaptations for both the patient and their loved ones. Photo: Agata Garpenlind Huntington’s disease is hereditary, genetic and usually begins between the ages of 30 and 50. In Sweden, around 1,000 people have the diagnosis and several t

https://www.multipark.lu.se/article/huntingtons-complex-brain-disease-affects-movement-thoughts-and-feelings - 2025-08-23

Viktoriia Nikulina, Nadiia Kravchenko, and Valeriia Haisanovska are three Ukrainian researchers that recently found new career paths in MultiPark's research groups. Since 24 February, nothing has been the same for Ukrainian researchers. In this urgent situation, MultiPark has offered some of them a sanctuary. They are eager to share their thoughts about how we may all contribute to this period to

https://www.multipark.lu.se/article/multipark-provides-safe-places-ukrainian-researchers - 2025-08-23